Toxoplasmosis (Congenital Defects - Toxoplasma gondii)
Overview
Plain-Language Overview
Congenital toxoplasmosis is an infection passed from a pregnant person to their baby caused by the parasite Toxoplasma gondii. This infection mainly affects the brain and eyes, leading to serious health problems. Babies born with this condition may have vision problems, seizures, or developmental delays. The parasite can cause inflammation and damage to the brain tissue and retina, which are critical for normal function. Early detection is important because the effects can be severe and long-lasting. The infection occurs when the parasite crosses the placenta during pregnancy. It is often linked to exposure to contaminated food, soil, or cat feces.
Clinical Definition
Congenital toxoplasmosis is a parasitic infection caused by vertical transmission of Toxoplasma gondii from mother to fetus during pregnancy. The core pathology involves fetal infection leading to neuroinflammation, intracranial calcifications, and chorioretinitis. The parasite invades the central nervous system and ocular tissues, causing hydrocephalus, microcephaly, and retinal lesions. The severity depends on the timing of maternal infection, with earlier infections causing more severe fetal damage. It is a major cause of congenital infections worldwide and can result in long-term neurological deficits and visual impairment. Diagnosis relies on serologic testing of mother and infant, imaging, and clinical findings. The condition highlights the importance of maternal screening and prevention during pregnancy.
Inciting Event
Maternal ingestion of undercooked meat containing Toxoplasma gondii tissue cysts.
Ingestion or inhalation of oocysts shed in cat feces contaminating soil or water.
Primary maternal infection with acute parasitemia during pregnancy enabling transplacental spread.
Reactivation of latent infection in immunocompromised pregnant women leading to fetal transmission.
Latency Period
Symptoms in the fetus or neonate typically develop weeks to months after maternal infection.
Congenital manifestations may be apparent at birth or present later in infancy with delayed neurologic or ocular signs.
The incubation period from maternal infection to fetal damage depends on gestational age at infection.
Diagnostic Delay
Nonspecific or absent symptoms in the mother during pregnancy lead to missed maternal diagnosis.
Neonatal symptoms such as chorioretinitis or hydrocephalus may be attributed to other causes initially.
Lack of routine prenatal screening for Toxoplasma infection delays diagnosis.
Serologic testing can be complicated by maternal antibody transfer, obscuring neonatal infection status.
Clinical Presentation
Signs & Symptoms
Jaundice and hepatosplenomegaly in the neonate
Seizures due to cerebral involvement
Chorioretinitis causing visual disturbances or blindness
Hydrocephalus from obstruction of cerebrospinal fluid flow
Poor feeding and failure to thrive
History of Present Illness
Newborns may present with jaundice, hepatosplenomegaly, and petechiae shortly after birth.
Progressive microcephaly, seizures, and developmental delay develop in affected infants.
Ocular symptoms include chorioretinitis causing visual impairment appearing in infancy or childhood.
Some infants are asymptomatic at birth but develop neurologic or ocular sequelae later.
Past Medical History
Maternal history of acute febrile illness with lymphadenopathy during pregnancy may be present.
Previous pregnancies complicated by fetal loss or congenital anomalies suggest possible undiagnosed infection.
Lack of prior immunity to Toxoplasma gondii increases risk of congenital transmission.
Maternal immunosuppression or chronic illness may affect infection risk and severity.
Family History
No direct heritable pattern as congenital toxoplasmosis results from vertical transmission of infection.
Family history of recurrent fetal losses or congenital infections may raise suspicion for infectious causes.
No known genetic syndromes associated with increased susceptibility to congenital toxoplasmosis.
Physical Exam Findings
Chorioretinitis with retinal scars and possible visual impairment
Hepatosplenomegaly due to systemic infection
Intracranial calcifications palpable on imaging correlating with neurological damage
Microcephaly reflecting impaired brain growth
Jaundice from liver involvement in severe cases
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established by detecting specific IgM or IgA antibodies against Toxoplasma gondii in the newborn or mother during pregnancy. Confirmatory diagnosis includes PCR testing for T. gondii DNA in amniotic fluid or neonatal blood. Imaging studies such as cranial ultrasound, CT, or MRI reveal characteristic intracranial calcifications and ventriculomegaly. Ophthalmologic examination identifies chorioretinitis lesions. A combination of serologic, molecular, and radiologic findings confirms congenital infection.
Pathophysiology
Key Mechanisms
Transplacental transmission of Toxoplasma gondii tachyzoites during maternal primary infection causes fetal tissue invasion and damage.
Intracellular parasitism leads to necrotizing inflammation in the brain, eyes, and other organs.
Immune-mediated granulomatous response attempts to contain the infection but contributes to tissue injury.
Disruption of normal neurodevelopment results from direct parasite damage and inflammatory cytokine effects.
Calcifications form due to chronic inflammation and necrosis in affected fetal tissues.
| Involvement | Details |
|---|---|
| Organs | Brain involvement leads to hydrocephalus, intracranial calcifications, and seizures in congenital toxoplasmosis. |
Eyes are commonly affected with chorioretinitis causing visual impairment or blindness. | |
Liver may show hepatosplenomegaly due to systemic infection and immune response. | |
| Tissues | Placental tissue is a key site for Toxoplasma gondii transmission from mother to fetus. |
Brain tissue is affected by cyst formation and inflammation causing neurological deficits in congenital toxoplasmosis. | |
Retinal tissue can develop chorioretinitis due to parasite invasion and immune-mediated damage. | |
| Cells | Macrophages phagocytose Toxoplasma gondii and present antigens to activate adaptive immunity. |
T cells (especially CD8+ cytotoxic T cells) mediate intracellular killing of infected cells harboring Toxoplasma. | |
Neurons can be infected by Toxoplasma gondii, contributing to neurological manifestations in congenital disease. | |
| Chemical Mediators | Interferon-gamma is critical for activating macrophages to control Toxoplasma infection. |
Tumor necrosis factor-alpha promotes inflammatory responses that help contain the parasite. | |
Interleukin-12 stimulates differentiation of T cells to produce interferon-gamma, enhancing immunity. |
Treatments
Pharmacological Treatments
Pyrimethamine
- Mechanism:
Inhibits dihydrofolate reductase, blocking folic acid synthesis in Toxoplasma gondii.
- Side effects:
Bone marrow suppression
Rash
Gastrointestinal upset
- Clinical role:
First-line
Sulfadiazine
- Mechanism:
Inhibits dihydropteroate synthase, interfering with folate synthesis in Toxoplasma gondii.
- Side effects:
Hypersensitivity reactions
Crystalluria
Bone marrow suppression
- Clinical role:
First-line
Leucovorin (Folinic acid)
- Mechanism:
Rescues host cells from pyrimethamine-induced folate deficiency.
- Side effects:
Allergic reactions
- Clinical role:
Adjunctive
Spiramycin
- Mechanism:
Macrolide antibiotic that concentrates in placenta to reduce fetal transmission of Toxoplasma gondii.
- Side effects:
Gastrointestinal upset
Allergic reactions
- Clinical role:
First-line for maternal infection without fetal disease
Non-pharmacological Treatments
Prenatal screening and counseling to prevent congenital transmission of toxoplasmosis.
Avoidance of undercooked meat and exposure to cat feces to reduce infection risk during pregnancy.
Supportive care including management of hydrocephalus and seizures in affected neonates.
Prevention
Pharmacological Prevention
Spiramycin administration during pregnancy to reduce fetal transmission
Pyrimethamine-sulfadiazine with folinic acid for confirmed fetal infection
Prenatal screening and treatment to prevent congenital disease
Prophylactic antibiotics in immunocompromised pregnant women
Prompt treatment of maternal infection to reduce fetal risk
Non-pharmacological Prevention
Avoidance of undercooked meat to reduce T. gondii exposure
Proper hand hygiene after handling cat litter or soil
Pregnant women avoiding contact with cat feces
Screening of pregnant women for T. gondii serostatus
Safe food handling and washing of fruits and vegetables
Outcome & Complications
Complications
Permanent visual impairment from retinal damage
Hydrocephalus requiring neurosurgical intervention
Seizures and epilepsy
Intellectual disability and neurodevelopmental delay
Fetal demise or stillbirth in severe cases
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Toxoplasmosis (Congenital Defects - Toxoplasma gondii) versus Cytomegalovirus (CMV) Congenital Infection
Toxoplasmosis (Congenital Defects - Toxoplasma gondii) | Cytomegalovirus (CMV) Congenital Infection |
|---|---|
Diffuse intracranial calcifications including basal ganglia and cortex | Periventricular calcifications on brain imaging |
Positive Toxoplasma gondii IgM or PCR in blood or amniotic fluid | Positive CMV PCR or culture from urine or saliva |
Chorioretinitis and hydrocephalus are more prominent | Sensorineural hearing loss is common |
Toxoplasmosis (Congenital Defects - Toxoplasma gondii) versus Rubella Congenital Syndrome
Toxoplasmosis (Congenital Defects - Toxoplasma gondii) | Rubella Congenital Syndrome |
|---|---|
Maternal exposure to Toxoplasma gondii via undercooked meat or cat feces | Maternal rubella infection during first trimester |
Chorioretinitis and intracranial calcifications | Congenital cataracts and patent ductus arteriosus |
Detection of Toxoplasma gondii IgM or PCR | Rubella-specific IgM antibodies in infant serum |
Toxoplasmosis (Congenital Defects - Toxoplasma gondii) versus Herpes Simplex Virus (HSV) Congenital Infection
Toxoplasmosis (Congenital Defects - Toxoplasma gondii) | Herpes Simplex Virus (HSV) Congenital Infection |
|---|---|
Often asymptomatic at birth with later development of chorioretinitis and hydrocephalus | Neonatal onset with vesicular skin lesions and encephalitis |
Toxoplasma gondii DNA detected by PCR in amniotic fluid or blood | HSV DNA detected by PCR in cerebrospinal fluid |
Chronic progressive neurological and ocular manifestations | Rapid progression with severe encephalitis |
Toxoplasmosis (Congenital Defects - Toxoplasma gondii) versus Zika Virus Congenital Syndrome
Toxoplasmosis (Congenital Defects - Toxoplasma gondii) | Zika Virus Congenital Syndrome |
|---|---|
Intracranial calcifications mainly in basal ganglia and cortex | Severe microcephaly with calcifications predominantly in the subcortical white matter |
Chorioretinitis and hydrocephalus are more typical | Arthrogryposis and hypertonia are common |
Maternal exposure to cat feces or undercooked meat | Maternal travel to or residence in Zika-endemic areas during pregnancy |
Toxoplasmosis (Congenital Defects - Toxoplasma gondii) versus Syphilis Congenital Infection
Toxoplasmosis (Congenital Defects - Toxoplasma gondii) | Syphilis Congenital Infection |
|---|---|
Positive Toxoplasma gondii serology or PCR | Positive non-treponemal and treponemal serologic tests in infant |
Chorioretinitis and intracranial calcifications | Snuffles, periostitis, and hepatosplenomegaly |
Intracranial calcifications and hydrocephalus on brain imaging | Periosteal bone changes on X-ray |